Rituximab: A new therapeutic monoclonal antibody for non-Hodgkin's lymphoma

被引：74
|
作者：
Scott, SD [1 ]
机构：
[1] Univ Iowa, Coll Pharm, Div Clin & Adm Pharm, Iowa City, IA 52242 USA
来源：
CANCER PRACTICE | 1998年 / 6卷 / 03期
关键词：
D O I：
10.1046/j.1523-5394.1998.006003195.x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：195 / 197
页数：3
相关论文
共 50 条
  • [41] RadioimmunotherapyPotential as a Therapeutic Strategy in Non-Hodgkin’s Lymphoma
    Ted Wun
    David S. Kwon
    Joseph M. Tuscano
    BioDrugs, 2001, 15 : 151 - 162
  • [42] Radioimmunotherapy as a therapeutic option for non-Hodgkin's lymphoma
    Macklis, Roger M.
    SEMINARS IN RADIATION ONCOLOGY, 2007, 17 (03) : 176 - 183
  • [43] Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma:: Safety and efficacy of re-treatment
    Davis, TA
    Grillo-López, AJ
    White, CA
    McLaughlin, P
    Czuczman, MS
    Link, BK
    Maloney, DG
    Weaver, RL
    Rosenberg, J
    Levy, R
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) : 3135 - 3143
  • [44] New treatment for orbital non-Hodgkin's lymphoma: 2 cases treated with rituximab
    Benabid, L
    Desablens, B
    Defossez, T
    Malthieu, D
    Milazzo, S
    Turut, P
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2005, 28 (07): : 769 - 771
  • [45] Treatment of B cell low grade non-Hodgkin's lymphoma (NHL) with anti-CD20 monoclonal antibody Rituximab®
    Federico, M
    Clo, V
    Vinci, G
    Sacchi, S
    ANNALS OF ONCOLOGY, 1998, 9 : 32 - 32
  • [46] CD47 IS AN ADVERSE PROGNOSTIC FACTOR IN NON-HODGKIN LYMPHOMA AND A THERAPEUTIC ANTIBODY TARGET THAT SYNERGIZES WITH RITUXIMAB
    Chao, M. P.
    Alizadeh, A.
    Tang, C. Z.
    Jan, M.
    Levy, R.
    Majeti, R.
    Weissman, I. L.
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (09) : S8 - S9
  • [47] Beyond Monoclonal Antibodies: New Therapeutic Agents in Non-Hodgkin's Lymphomas
    Delmonte, Angelo
    Ghielmini, Michele
    Sessa, Cristiana
    ONCOLOGIST, 2009, 14 (05): : 511 - 525
  • [48] New advances in the treatment of non-Hodgkin lymphoma with monoclonal antibodies
    Buske, C
    Feuring-Buske, M
    Unterhalt, M
    Hiddemann, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 124 (27) : 842 - 847
  • [49] Drug therapy: Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma
    Cheson, Bruce D.
    Leonard, John P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (06): : 613 - 626
  • [50] Immunotherapy for non-Hodgkin's lymphoma: Monoclonal antibodies and vaccines
    Maloney, DG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) : 6421 - 6428
12345